Jagsonpal Pharma

Hold

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE048B01035
NSEID: JAGSNPHARM
BSEID: 507789

INR

214.00

12.1 (5.99%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.22 lacs

Click here to access the older version

Cash Flow

Jagsonpal Pharma Cash flow Statement

Figures in Rs cr

Standaloned Cash Flow Results

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Mar'19

Compare Cash Flow Results of Jagsonpal Pharma

Select Peers

Figures in Rs cr

standaloned Cash Flow Results

Change(INR)

Change(%)

Profit Before Tax

29.87

2259.57

-2,230.00

-98.68%

Adjustment

8.27

161.91

-153.00

-94.89%

Changes In working Capital

5.54

-40.95

45.00

113.53%

Cash Flow after changes in Working Capital

43.68

2380.53

-2,337.00

-98.17%

Cash Flow from Operating Activities

35.17

1982.97

-1,947.00

-98.23%

Cash Flow from Investing Activities

-24.55

-1919.22

1,895.00

98.72%

Cash Flow from Financing Activities

-8.91

-8.68

0.00

-2.65%

Net Cash Inflow / Outflow

1.71

55.07

-54.00

-96.89%

Opening Cash & Cash Equivalents

11.05

134.13

-123.00

-91.76%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

0.00

0.00%

Closing Cash & Cash Equivalent

12.76

189.2

-177.00

-93.26%

Cash Flow - Snapshot (Standalone) - Mar'24

YoY Growth in year ended Mar 2024 is -24.62% vs 575.25% in Mar 2023

Mar'24

Mar'23

Change(%)

Cash Flow from Operating Activities

35.17

46.66

-24.62%